Mobile-health Network Solutions Class A (MNDR) AI Stock Analysis

• Market Cap: $2.74M
• Dividend Yield: N/A
• Average Volume (3M): 146.17K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.10
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 73
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Care Facilities
• EPS (TTM): -0.34
• Shares Outstanding: 2,890,756
• 10 Day Avg. Volume: 340,392
• 30 Day Avg. Volume: 146,174
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Mobile-health Network Solutions is experiencing strong revenue growth but continues to struggle with profitability and cash flow challenges. Technical analysis shows a bearish trend, and valuation metrics are unattractive due to ongoing losses. The company needs significant improvements in operational efficiency and strategic initiatives to improve its financial standing.

Mobile-health Network Solutions Class A Business Overview & Revenue Model

Company Description

Mobile-health Network Solutions Class A (MNDR) is a leading company in the digital healthcare sector, specializing in the development and provision of mobile health technology solutions. The company focuses on creating innovative applications and platforms that enhance patient care, improve healthcare delivery, and streamline communication between healthcare providers and patients. MNDR's core products include mobile health applications, telemedicine platforms, and data analytics services designed to optimize healthcare outcomes.

How the Company Makes Money

MNDR generates revenue primarily through subscription fees for its mobile health applications and telemedicine platforms, which are offered to both healthcare providers and patients. The company also earns income from licensing agreements with hospitals and healthcare networks that integrate MNDR's technology into their existing systems. Additionally, MNDR partners with pharmaceutical companies and research institutions, providing data analytics services that offer valuable insights into patient health trends, treatment efficacy, and healthcare delivery improvements. These partnerships enhance MNDR's market position and contribute significantly to its revenue streams.

Mobile-health Network Solutions Class A Financial Statement Overview

Summary

Mobile-health Network Solutions has experienced impressive revenue growth but faces significant challenges in achieving profitability and managing cash flows. While the balance sheet shows some stability, the negative net income impacts key profitability and cash flow metrics. The company should focus on operational efficiencies and strategic initiatives to enhance profitability and cash conversion.

Income Statement

Over the past year, Mobile-health Network Solutions demonstrated significant revenue growth of 142% and a considerable improvement in gross profit margin, moving from a negative to 18.17%. However, the company is still grappling with profitability issues, as evidenced by negative EBIT and net profit margins. These financial strains highlight a need for improved operational efficiencies and cost management.

Balance Sheet

The company's balance sheet reveals a reasonable debt-to-equity ratio of 0.09, reflecting a conservative leverage approach. However, the return on equity (ROE) is negative due to consistent net losses, and the equity ratio stands at 52%, indicating moderate stability. The positive shift in stockholders' equity suggests efforts to strengthen the financial foundation, yet profitability remains a concern.

Cash Flow

Cash flow analysis shows challenges, with the operating cash flow to net income ratio negative, indicating cash flow management issues. Despite a substantial increase in free cash flow from the previous year, the free cash flow to net income ratio remains negative. This suggests ongoing difficulties in transforming revenue into cash, necessitating improved cash management strategies.

Breakdown
Jun 2024	Jun 2023	Jun 2022	Jun 2021
Income Statement		Total Revenue
13.97M	5.77M	5.14M	1.92M
	Gross Profit
2.54M	-1.02M	594.99K	-200.45K
	EBIT
-15.70M	-2.41M	142.41K	-474.86K
	EBITDA
-15.55M	-3.19M	206.45K	-597.73K
	Net Income Common Stockholders
-15.60M	-2.35M	68.16K	-460.15K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
6.77M	1.64M	7.36M	121.39K
	Total Assets
7.95M	2.54M	7.73M	693.92K
	Total Debt
376.01K	292.45K	42.48K	60.79K
	Net Debt
-6.33M	-1.35M	-7.32M	-60.60K
	Total Liabilities
3.81M	2.82M	1.67M	5.18M
	Stockholders Equity
4.14M	-271.32K	6.06M	-4.48M
Cash Flow		Free Cash Flow
-6.54M	-1.78M	706.25K	―
	Operating Cash Flow
-6.41M	-1.65M	717.44K	-475.05K
	Investing Cash Flow
-134.21K	-136.29K	-11.19K	―
	Financing Cash Flow
10.88M	-4.25M	6.79M	387.59K

Mobile-health Network Solutions Class A Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.56
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MNDR, the sentiment is Negative. The current price of 1.56 is above the 20-day moving average (MA) of 1.52, below the 50-day MA of 2.28, and below the 200-day MA of 3.89, indicating a bearish trend. The MACD of -0.17 indicates Negative momentum. The RSI at 40.74 is Neutral, neither overbought nor oversold. The STOCH value of 48.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MNDR.

Mobile-health Network Solutions Class A Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DCGO	63 Neutral	$230.87M	12.51	6.43%	―	-1.24%	196.79%
TOI	56 Neutral	$212.11M	―	-174.88%	―	21.33%	23.37%
Sector *	56 Neutral	$4.35B	2.82	-19.47%	5.13%	19.93%	-60.03%
AMS	53 Neutral	$18.01M	8.37	9.23%	―	32.90%	262.22%
PIII	42 Neutral	$54.44M	―	-124.59%	―	18.48%	-37.42%
MNDR	39 Underperform	$2.74M	―	-376.93%	―	―	―
MODV	34 Underperform	$20.94M	―	-341.96%	―	1.32%	1.95%